Early research (Phase 1)Ended earlyNCT01482013
What this trial is testing
Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease
Who this might be right for
Mild Alzheimer's DiseaseMild Cognitive Impairment
High Point Pharmaceuticals, LLC. 7